Company registration number: 15746137
COMPANY INFORMATION
CONTENTS
STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2025
Page 1
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 JULY 2025
The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
The notes on pages 3 to 6 form part of these financial statements.
Page 2
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
Dedomena Bidco Limited is a private company, limited by shares, incorporated in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.
The Company's functional and presentational currency is GBP.
These accounts are presented from the date of incorporation 28 May 2024 to the period ended 31 July 2025.
company's registered number and registered office address can be found on the Company Information page.
The Company's functional and presentational currency is GBP.
These accounts are presented from the date of incorporation 28 May 2024 to the period ended 31 July 2025.
2.Accounting policies
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The following principal accounting policies have been applied:
The financial statements have been prepared on a going concern basis. For the year ended 31 July 2025, the company incurred a net loss of £2,644,689 and had net current liabilities of £51,017,811 as at the balance sheet date. These conditions indicate the existence of a material uncertainty which may cast significant doubt on the company’s ability to continue as a going concern.
However, the directors have received confirmation of support from the company’s ultimate parent undertaking, Inflexion Private Equity Partners LLP, confirming that it will provide financial support to the company to enable it to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements. The directors have no reason to believe that this support will not be forthcoming.
Taking into account the support from the parent company and the group’s overall financial position, the directors consider it appropriate to prepare the financial statements on a going concern basis. Accordingly, the financial statements do not include the adjustments that would result if the company were unable to continue as a going concern.
However, the directors have received confirmation of support from the company’s ultimate parent undertaking, Inflexion Private Equity Partners LLP, confirming that it will provide financial support to the company to enable it to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements. The directors have no reason to believe that this support will not be forthcoming.
Taking into account the support from the parent company and the group’s overall financial position, the directors consider it appropriate to prepare the financial statements on a going concern basis. Accordingly, the financial statements do not include the adjustments that would result if the company were unable to continue as a going concern.
Page 3
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
2.Accounting policies (continued)
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.
Basic financial assets and liabilities
Basic financial assets and liabilities, which include trade and other receivables, cash and bank balances, trade payables and other liabilities are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables and payables due with the operating cycle fall into this category of financial instruments.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Derecognition of financial liabilities
Financial liabilities are derecognised when, and only when, the Company’s contractual obligations are discharged, cancelled, or they expire.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Basic financial assets and liabilities, which include trade and other receivables, cash and bank balances, trade payables and other liabilities are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables and payables due with the operating cycle fall into this category of financial instruments.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Derecognition of financial liabilities
Financial liabilities are derecognised when, and only when, the Company’s contractual obligations are discharged, cancelled, or they expire.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Page 4
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Page 5
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 JULY 2025
On 25 June 2025, the Company entered into a £12.0 million term loan facility with Ares. The loan bears interest at a variable rate of SONIA plus 5.5% per annum.
The facility has a term of seven years from the date of inception and is repayable in full at the end of the term on 25 June 2032. There are no scheduled repayments of principal during the term of the loan.
The loan is therefore classified as a non-current liability, except for any interest accrued at the reporting date, which is included within current liabilities.
The facility has a term of seven years from the date of inception and is repayable in full at the end of the term on 25 June 2032. There are no scheduled repayments of principal during the term of the loan.
The loan is therefore classified as a non-current liability, except for any interest accrued at the reporting date, which is included within current liabilities.
The Company's immediate parent company is Dedomena Midco 2 Limited, a company incorporated in England and Wales. The ultimate parent company is Dedomena Topco Limited, a company incorporated in England and Wales.
The smallest and largest group in with the results of the company will be consolidated is in Dedomena Topco Limited for the year ended 31 July 2025. Consolidated accounts may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ.
The directors consider Inflexion Private Equity Partners LLP to be the ultimate controlling party, due to its majority indirect shareholding in Dedomena Topco Limited.
The smallest and largest group in with the results of the company will be consolidated is in Dedomena Topco Limited for the year ended 31 July 2025. Consolidated accounts may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ.
The directors consider Inflexion Private Equity Partners LLP to be the ultimate controlling party, due to its majority indirect shareholding in Dedomena Topco Limited.
Page 6